Year All2024202320222021 5/7/2024 Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Read More 5/6/2024 Neumora Therapeutics to Participate in Upcoming Conferences in May Read More 4/15/2024 Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study Read More 3/13/2024 Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days Read More 3/7/2024 Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Read More 1/22/2024 Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer Read More 1/2/2024 Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference Read More
5/7/2024 Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Read More
3/7/2024 Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Read More
